Global Hospitals Group offers the country’s Largest Liver Transplantation
By admin
January 29th, 2010
The Global Hospitals Group today announced the largest comprehensive liver transplantation programme in the country providing hope for those suffering from end stage liver disease.
Global’s liver transplant program is the only program in India providing complete range of liver transplantation including cadaver and living donor transplants, split and auxiliary transplants, and our success rate is close to 90% on par with that of the best centers in the world.
Dr. Ravindranath, himself an FRCS from both Glasgow and Edinburgh, is one of the pioneers of liver transplantation in India. He had abandoned his lucrative career in some of the best hospitals in Britain and returned to India for good with a view to making liver transplants accessible and affordable to patients crippled with end-stage liver disease. Earlier, Indian patients had to go to countries like the U.K. and wait indefinitely for a cadaver donor liver and spend a fortune to undergo the procedure.
Global Group is today India’s fastest growing chain of hospitals offering tertiary-level super specialty services in a host of disciplines, and an undisputed leader in liver and pancreatic diseases and multi organ transplantation.
World-renowned liver transplant surgeon, Dr. Mohamed Rela, heads the Global Group’s liver transplantation program in India. During his 20-year-career, Dr. Mohamed Rela has performed more than 1300 liver transplants, and entered the Guinness Book of World Records by successfully carrying out liver transplantation in a 5-day-old baby. To his credit he has done largest number of liver transplant in children, split liver transplants and auxiliary transplantation.
Dr. K. Ravindranath, renowned surgical gasteroenterologist & lap surgeon and Chairman and Managing Director, Global Hospitals Group, said, “The Global Group has had the distinction of having undertaken the largest number of cadaver liver transplants in the country.”
There are ten transplant surgeons in Bangalore/Hyderabad/Chennai which is the largest team in the country supported by several hepatologists, critical care specialists and host of support specialties.
Global Hospitals in Hyderabad and Chennai have performed nearly 100 successful liver transplants. Global’s world-class services at affordable cost have drawn patients from countries like Pakistan, Iran, Iraq, Afghanistan, Nigeria, Sri Lanka and the US.
Dr. N. K. Venkataramana, Vice-Chairman, BGS Global Hospitals, said, “Global has the largest liver transplantation unit in the country and the largest number of qualified liver surgeons, hepatologists, liver anesthesiologists and liver intensivists. The group has the maximum number of dedicated ICU beds with all support facilities. The transplant team comprises highly skilled and trained professionals from various disciplines – surgery, anesthesia, hepatology, critical care, interventional radiology, imaging and nuclear medicine, endoscopy, microbiology, immunology, and blood transfusion and paramedical staff.”
Filed under Health Care / Hospitals | Tags: Country, Largest, Liver, program, Transplant | Comment Below
Related Press Releases Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)November 29th, 2009 ATIR(TM) for Reduction of Transplant Related Mortality Following an Allogeneic Stem Cell Transplantation Using a Mismatched Donor
AMSTERDAM, November 30 - Biopharmaceutical company Kiadis Pharma announces today that the first
patients have been enrolled in its multinational registration clinical trial
with ATIR(TM). The study is designed to show reduction in transplant related
mortality (TRM) after one year following an allogeneic stem cell
transplantation with a mismatched (haplo-identical) donor in blood cancer
patients eligible for an allogeneic stem cell transplantation but without
having a matched donor available. 'Clean' has to be 'Cool'October 14th, 2009 LONDON - Don't wait until you go to hospital. That is the message emerging strongly from early results of a Survey by the Patients Association. Vital Therapies Initiates Liver Stabilization TrialOctober 1st, 2009 SAN DIEGO -
- Pivotal ELAD Study in United States and Europe
Vital Therapies, Inc. (VTI), today announced that the first subject has been enrolled in a pivotal trial of its ELAD human cell-based liver assist system at California Pacific Medical Center (CPMC) in San Francisco. Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford UniversityAugust 3rd, 2009 PALO ALTO, California -
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that it has licensed the exclusive worldwide rights to novel Hepatitis C Virus (HCV) technology from Stanford University. This technology, discovered in the lab of Stanford scientist and Eiger founder Dr. Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and LymphomaJune 2nd, 2009 JERUSALEM - The Gamida Cell-Teva Joint Venture announced today that five prestigious cord blood transplantations centers in Spain, three in Barcelona and two in Valencia, have joined the Excel study. Participating clinical sites include, in alphabetical order: - Hospital Clinic of Barcelona, Barcelona Principal Investigator, Dr. Randomized Controlled Trial of Radioactive Resin Microspheres Demonstrates Significant Delay in Progression of Disease in Patients With Colorectal Cancer Liver Metastases who Have Exhausted ChemotherapyMay 31st, 2009 ORLANDO, Florida - The time to progression of disease in patients with colorectal cancer liver metastases who have exhausted all chemotherapy options can be more than doubled through the use of radioactive resin microspheres, according to the results of a prospective randomized controlled trial presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).[1] The multicenter phase III study compared the use of 5-fluorouracil (5FU) alone to 5FU plus 90Y resin microspheres (SIR-Spheres; Sirtex Medical, Sydney) and was conducted by a collaboration of university hospitals in Belgium. "Patients with colorectal cancer liver metastases who are resistant or intolerant of chemotherapy should be considered for salvage therapy using 90Y resin microspheres combined with 5FU-based chemotherapy," said Dr Alain Hendlisz, Head of Digestive Oncology and Gastroenterology at Institut Jules Bordet Université Libre de Bruxelles, Brussels, Belgium, and principal investigator of the study. CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information SystemsMay 11th, 2009 GRAND RAPIDS, Michigan - For the First Time, Hospitals Using MEDITECH and Other HIT Solutions can use CPMRC's Interdisciplinary Clinical Content Through TSG's Integrated Portal Solutions
CPM Resource Center (CPMRC) and The Shams Group (TSG) have partnered to provide small- and medium-sized hospitals with next-generation nursing and interdisciplinary documentation that integrates with their current health information systems. CPMRC provides evidence-based clinical content products and practice transformation services that assist healthcare organizations in creating a healthy work culture and interdisciplinary integration based on the CPM Professional Practice Framework(TM). An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant RecipientsApril 23rd, 2009 COLUMBIA, Maryland - The results of the largest study performed to date will be presented during the International Society for Heart and Lung Transplantation Annual Meeting in Paris, France on April 24, 2009
Since it was cleared as an in vitro assessment of cell-mediated immunity in immunosuppressed patient populations, numerous clinical investigations have contributed to defining the role of the Cylex ImmuKnow assay among recipients of solid organ transplants. (Logo: www.newscom.com/cgi-bin/prnh/20090424/NE99362 )
In the largest immune monitoring experience in heart transplantation, investigators at UCLA's David Geffen School of Medicine followed 337 cardiac transplant patients with ImmuKnow to determine whether ImmuKnow assay values can be correlated with the incidence of infection or rejection. Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow TransplantationsApril 7th, 2009 AMSTERDAM - ATIR(TM) Data Presented at the Annual EBMT Presidential Symposium
Biopharmaceutical company Kiadis Pharma reported preliminary clinical data on ATIR(TM) showing its potential in mismatched bone marrow transplantations. Data was presented by the company's principal investigator Dr. King's College Hospital Awards NCR the Largest Self-Service Healthcare Deal in EuropeApril 6th, 2009 LONDON - Patients at King's College Hospital NHS Foundation Trust (www.kch.nhs.uk/) in London are to benefit from a groundbreaking new patient automated arrival system from NCR Corporation (www.ncr.com/) (NYSE: NCR). The solution is designed to reduce queuing, increase the immediacy and privacy of patient communications and cut down on paperwork allowing staff to focus on providing the highest standards of clinical care.
Related News Achillion Pharmaceuticals shares rise on positive early-stage hepatitis C drug dataDecember 16th, 2009 Achillion shares rise on hepatitis C drug dataNEW YORK — Shares of Achillion Pharmaceuticals Inc. surged Wednesday after the company said its hepatitis C drug candidate showed positive "proof-of-concept" results, while meeting safety and tolerability goals in an early-stage study. 6 hospitals to sue Mass. for millions of dollars, say 2006 health care law shortchanged themNovember 30th, 2009 6 hospitals to sue Mass., say shortchanged by lawBOSTON — Six Massachusetts hospitals are suing the state, saying they were shortchanged by the 2006 health care law. The hospitals claim the state violated a law requiring health care providers be adequately reimbursed for caring for Medicaid and Medicare patients. Biocon and HCG group of hospitals ltd. join hands to fight against cervical cancerDecember 10th, 2009 BANGALORE - Biocon and HCG group of hospitals today announced their partnership to conduct a study to evaluate the potential benefits of BIOMAb EGFR(r) in cervical cancer patients.This unique molecule would take healthcare for cervical cancer patients to a new threshold. BIOMAb EGFR(r) is Biocon's humanized monoclonal antibody which is approved for the treatment of head and neck cancers in India. Pittsburgh-based West Penn Allegheny Health System cuts 213 jobs at hospitals, officesJanuary 7th, 2010 Pittsburgh-based hospital network cuts 213 jobsPITTSBURGH — Southwestern Pennsylvania's second-largest hospital network has cut 213 full-time jobs in its six hospitals and corporate offices. West Penn Allegheny County Health System posted its second consecutive profitable quarter in December, but chief executive Christopher Oliva says more needs to be done to improve operations. India's Spice mobile chooses Bangladesh for global debutDecember 23rd, 2009 DHAKA - India's Spice mobiles have debuted in the international market by launching four handsets in Bangladesh, the largest growing market for cellphones in the neighbourhood. "We chose to enter the international market with Bangladesh as the country offers great opportunities for mobile handset companies with huge untapped penetration," Kunal Ahooja, CEO of Spice Mobiles Ltd, said at the launch here Tuesday. Reynolds offers buyouts to manufacturing workers as cigarette demand declines industrywideDecember 4th, 2009 Reynolds offers buyouts to manufacturing workersRICHMOND, Va. — R.J. Reynolds Tobacco Co., maker of Camel cigarettes, said Friday it is offering buyouts to about 1,800 workers at its North Carolina factories to cut costs. Colorado-based Resort Technology Partners offers ski resort info on iPhone 3GSDecember 4th, 2009 Colorado company offers ski info on iPhone 3GSAVON, Colo. — Skiers stuck on a mountain with no trail map but with an iPhone 3GS in their pockets could get help finding their way with another iPhone application from a Colorado company. Global Defense Technology & Systems closes initial public offeringNovember 25th, 2009 Global Defense Technology & Systems closes IPOSAN FRANCISCO — Global Defense Technology & Systems Inc. said Wednesday that it closed its initial public offering of 4.6 million common shares, which were priced at $13 apiece and yielded $36.3 million in net proceeds. Global travel group opposes proposed Delta-JAL tie-up as eroding competitionJanuary 7th, 2010 Global travel group opposes Delta-JAL tie-upTOKYO — A group representing business travelers is opposing the proposed tie up between Delta Air Lines and money-losing Japan Airlines as bad for competition. Kevin Mitchell, chairman of the Business Travel Coalition, based in Brussels, said Thursday that the proposed SkyTeam alliance would likely create a monopoly, totaling 62 percent market share on routes between Japan and the U.S., up from a third. EU approves Liberty Global's purchase of German cable TV operator Unitymedia for $5.2 blnJanuary 25th, 2010 EU approves Liberty Global purchase of UnitymediaThe European Commission has approved Liberty Global's acquisition of Germany's second-largest cable television operator for $5.2 billion. Liberty Global Inc.
|
|
